Affyimmune Therapeutics, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Holding
- Established
- 2016-01-01
- Employees
- 1
- Market Cap
- -
- Website
- http://affyimmune.com
Study of AIC100 CAR T Cells in Relapsed/Refractory Thyroid Cancer
Phase 1
Active, not recruiting
- Conditions
- Anaplastic Thyroid CancerRelapsed/Refractory Poorly Differentiated Thyroid Cancer
- Interventions
- Biological: AIC100 CAR T Cells
- First Posted Date
- 2020-06-09
- Last Posted Date
- 2025-03-30
- Lead Sponsor
- AffyImmune Therapeutics, Inc.
- Target Recruit Count
- 70
- Registration Number
- NCT04420754
- Locations
- 🇺🇸
City of Hope National Medical Center, City of Hope Medical Center, Duarte, California, United States
🇺🇸Northwestern Memorial Hospital, Chicago, Illinois, United States
🇺🇸Weill Cornell Medical College, New York, New York, United States
© Copyright 2025. All Rights Reserved by MedPath